The UK’s R&D Magnet: Who is it Really Attracting?

Our 2026 Strategic Take:

The transition to the Merged RDEC scheme represents a fundamental shift from 'subsidising innovation' to 'rewarding UK infrastructure.' While the Treasury aims to anchor global giants to our shores, our analysis shows a growing '30% Trap' where high-growth scale-ups are accidentally losing millions in support simply by expanding their non-R&D teams. In 2026, R&D eligibility is no longer just a tax calculation—it is a boardroom scaling decision.

For decades, the UK has positioned itself as a global anchor for innovation. The strategy was built on a "whole-life" approach—an ecosystem designed to support a company from its first spark of an idea to global commercialisation.

By offering a seamless pathway of incentives, the UK created a unique gravitational pull:

The Seed Stage: Tax-efficient investment through EIS (Enterprise Investment Scheme) and SEIS (Seed EIS) to de-risk early-stage capital.
The Growth Stage: Direct funding through Innovate UK grants to jumpstart high-risk projects.
The Development Stage: Robust R&D support, historically featuring a generous SME R&D Tax Relief and a lower-rate R&D Expenditure Credit (RDEC) for established players.
The Commercial Stage: The Patent Box, which slashes Corporation Tax to 10% on profits derived from patented inventions where the UK company holds the IP, specifically designed to anchor UK-based innovation.

This "cradle-to-exit" framework made the UK a primary destination for both startups and international firms looking to register subsidiaries and hire engineering talent. However, in the last 24 months, the "magnetic field" has shifted. We have moved from a borderless, wide-reaching incentive to a localised, more concentrated one.

The question for 2026: Is the UK’s magnet still strong enough to attract and keep innovators within its realm, or are the most agile players beginning to drift away?

The Shift in Gravitational Pull

Until recently, the UK was a global outlier. You could set up a UK headquarters, claim UK tax relief, but "export" that investment to developers in Eastern Europe or laboratories in Asia.

With the introduction of the Merged RDEC scheme, the rules of attraction were rewritten. Under this new framework:

Subcontracted R&D is now generally required to be performed in the UK to qualify, unless specific conditions can be met (these do not include cost savings or convenience).
Externally Provided Workers (EPWs) Externally Provided Workers (EPWs) must generally be subject to UK PAYE/NIC to qualify.

The message from the Treasury was clear: To benefit from the UK's pull, you must contribute to its core.

The Great Divergence: Large vs. Small

While total R&D expenditure remains robust at over £46 billion, the profile of who is attracted in has fundamentally changed. Data suggests the UK is trading a broad, diverse ecosystem of small "sparks" for a concentrated core of industrial "anchors."

The table below highlights the stark reality: the system is significantly more attractive for large companies now than it was three years ago, while many startups have seen their support effectively halved.

The "Shifting Magnetism" Table

Table showing the changes in benefit levels for Large Companies and SMEs.

Critical Analysis: A Corporate Powerhouse or a Startup Sandbox?

1. The "Large Company" RDEC Surge

Large firms are the clear winners of the recent reforms. Because RDEC is an "above-the-line" credit, it shows up as income before tax. For a global CFO in the US or Japan, the UK subsidiary suddenly looks significantly more profitable on paper, triggering more internal investment from global headquarters.

Furthermore, Large Company claimants now have scope to claim UK-based subcontractor and EPW costs, which were significantly more restricted under the previous RDEC rules.

2. The Startup "30% Trap"

To protect the most innovative small firms, the government introduced ERIS (Enhanced R&D Intensive Support). If a loss-making startup spends 30% or more of its total expenditure on R&D, it can still recoup roughly 27p for every £1 spent.

However, this is a precarious position. For a pre-revenue company, hitting 30% is easy. But as soon as they scale—hiring sales staff, marketing, or leasing a larger office—their R&D ratio often drops. Many high-growth companies are accidentally drifting out of the ERIS zone into the standard merged scheme, where the benefit is slashed to 16.2%.

3. The Collapse of First-Time R&D Claimants

The data confirms a "cleansing" of the claimant pool. First-time applications from SMEs have fallen significantly—by around 45% from their peak, based on recent HMRC statistics. For many smaller firms, the increased compliance burden combined with much lower claim rates, has made the scheme "not worth the effort."

A Final Thought

The merged RDEC restrictions and the 2023 R&D claim rate changes were a "stress test" for the UK’s attractiveness. By requiring R&D to stay on-shore and shifting the financial weight toward larger entities, the government has stopped subsidising "fringe" innovation and started demanding that global firms build substantive, long-term infrastructure here.

The UK's magnet is still pulling—but it's now designed to attract industrial giants and high-intensity specialists, rather than a wide net of small-scale experimenters.

The key question is: Is the UK building a sustainable future, or are we neglecting the small startups that are destined to be the large companies of 2035?

Get R&D claim advice and support